Clinical Trial: Clinical Research on Effectiveness and Safety of Treatment of Severe Oligospermia or Azoospermia With uFSH

Study Status: Recruiting
Recruit Status: Unknown status
Study Type: Interventional

Official Title: Effectiveness and Safety of uFSH for Severe Oligospermia or Azoospermia:A Multi-center,Open,Randomized,Interventional,and Phase4 Trial in China

Brief Summary: The purpose of this study is to determine whether uFSH is effective and safe in the treatment of male patients with severe oligospermia or azoospermia.

Detailed Summary:
Sponsor: Livzon Pharmaceutical Group Inc.

Current Primary Outcome:

  • Sperm density [ Time Frame: 6 month ]
  • (A + B)grade sperm and sperm activity rate [ Time Frame: 6 month ]
  • A grade sperm [ Time Frame: 6 month ]
  • semen volume [ Time Frame: 6 month ]
  • sex hormone levels [ Time Frame: 6 month ]
  • testis volume [ Time Frame: 6 month ]


Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Livzon Pharmaceutical Group Inc.

Dates:
Date Received: December 2, 2014
Date Started: August 2014
Date Completion:
Last Updated: December 4, 2014
Last Verified: August 2014